Australia releases guidance on Class III devices and active implantables:
This article was originally published in Clinica
Australia's Therapeutic Goods Administration (TGA) has published "Australian Medical Devices Guidance Document 13 - variants for Class III and AIMD Medical Devices", which addresses the criteria for entering Class III and active implantable medical devices in the Australian Register of Therapeutic Goods (ARTG). It covers "same kind of medical device", unique product identifiers and variants. The document is one of a series explaining key areas of the new regulatory system for medical devices. The guidance is available via: www.tga.gov.au/new/new.htm
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.